Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson's disease

Alexander I. Tröster
DOI: https://doi.org/10.1080/14737175.2024.2360121
IF: 4.287
2024-06-01
Expert Review of Neurotherapeutics
Abstract:Introduction Deep brain stimulation (DBS) is an effective treatment for Parkinson's disease (PD) motor symptoms that improves function and quality of life in appropriately selected patients. Because mild to moderate cognitive declines can follow DBS and impact quality of life in a minority of patients, an important consideration involves the cognitive deficit and its prediction.
pharmacology & pharmacy,clinical neurology
What problem does this paper attempt to address?
The paper primarily explores the cognitive changes that may occur in patients with Parkinson's disease (PD) after receiving deep brain stimulation (DBS) treatment and attempts to identify the risk factors and predictors of these cognitive changes. Specifically: 1. **Research Background**: DBS is an effective method for treating motor symptoms of Parkinson's disease, capable of improving patients' functionality and quality of life. However, in a minority of patients, DBS may lead to mild to moderate cognitive decline, thereby affecting their quality of life. 2. **Research Focus**: The paper mainly focuses on relevant literature published from 2018 to 2024, particularly studies that use comprehensive neuropsychological assessments. The emphasis is on exploring the cognitive outcomes of bilateral subthalamic nucleus (STN) DBS. 3. **Risk Factors and Predictors**: The authors point out that age and preoperative neuropsychological status are the most reliable predictors. Additionally, many other potential risk factors have been identified, but specific predictive models have not yet been established. 4. **Future Directions**: Future research should utilize multicenter collaborations, adhere to standardized reporting guidelines, and leverage advancements in stimulation technology, biomarkers, and artificial intelligence to further explore these issues. Additionally, DBS studies should be conducted in diverse patient populations to better understand the mechanisms of cognitive decline and its mitigation methods. In summary, this paper aims to propose future research directions through a comprehensive analysis of existing research findings, with the goal of reducing cognitive side effects after DBS surgery and improving the treatment outcomes for Parkinson's disease patients.